Patients with cystic fibrosis and advanced lung disease benefit from lumacaftor/ivacaftor treatment

Ejiofor, LCK; Mathiesen, IHM; Jensen-Fangel, S; Olesen, HV; Skov, M; Philipsen, LKD; Pedersen, CL; Pressler, T

Ejiofor, LCK (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Infect Dis, Esther Moellers Vej 6,Opgang 86,3 Sal, DK-2100 Copenhagen, Denmark.

PEDIATRIC PULMONOLOGY, 2020; 55 (12): 3364

Abstract

Background Several studies have assessed safety and efficacy outcomes for lumacaftor/ivacaftor therapy. We report on lumacaftor/ivacaftor's impact on ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索